"
Team:Michigan/Test Css
From 2012.igem.org
(Difference between revisions)
| (87 intermediate revisions not shown) | |||
| Line 1: | Line 1: | ||
<html> | <html> | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| + | <script type="text/javascript"> | ||
| - | + | $(function(){ | |
| + | $('.slideshow img:gt(0)') | ||
| + | .hide(); | ||
| + | setInterval(function(){ | ||
| + | $('.slideshow :first-child') | ||
| + | .fadeOut() | ||
| + | .next('img') | ||
| + | .fadeIn() | ||
| + | .end() | ||
| + | .appendTo('.slideshow');}, 6000); | ||
| + | }); | ||
| + | </script> | ||
| + | |||
| + | <head> | ||
<style type="text/css"> | <style type="text/css"> | ||
| Line 25: | Line 28: | ||
padding:90px 0 0 0; | padding:90px 0 0 0; | ||
} | } | ||
| - | #navigation ul, #navigation li{ list-style:none; padding:0; margin: | + | #navigation ul, #navigation li{ list-style:none; padding:0; margin:0; display:inline; } |
| - | #navigation ul li{ float:left; position:relative; } | + | #navigation ul li{ |
| + | float:left; | ||
| + | position:relative; | ||
| + | |||
| + | } | ||
| + | |||
#navigation ul li a{ | #navigation ul li a{ | ||
| - | + | display:block; | |
padding:7px 12px; | padding:7px 12px; | ||
| - | margin: | + | margin-left:auto; |
| + | margin-right:auto; | ||
font-size:18px; | font-size:18px; | ||
white-space:nowrap; | white-space:nowrap; | ||
| Line 38: | Line 47: | ||
} | } | ||
#navigation ul li a:hover{} | #navigation ul li a:hover{} | ||
| + | #navigation ul li ul li a{ | ||
| + | width: 75px; | ||
| + | } | ||
| + | #navigation ul ul li a:hover{ | ||
| + | background:#063257; | ||
| + | background-repeat:repeat-x; | ||
| + | color:#fff080; | ||
| + | background-size:200%; | ||
| + | } | ||
#navigation ul ul{ | #navigation ul ul{ | ||
position:absolute; | position:absolute; | ||
height:-99999px; | height:-99999px; | ||
| - | left: | + | margin-left:auto; |
| + | margin-right:auto; | ||
opacity: 0; /* Hide sub level */ | opacity: 0; /* Hide sub level */ | ||
-webkit-transition: opacity .5s ease-in-out; | -webkit-transition: opacity .5s ease-in-out; | ||
| Line 56: | Line 75: | ||
} | } | ||
| - | #navigation ul ul ul { | + | #navigation ul ul ul { |
| - | + | margin-left:auto; | |
| - | + | margin-right:auto; | |
| - | + | ||
| + | |||
opacity: 0; | opacity: 0; | ||
-webkit-transition: opacity .5s ease-in-out; /* Hide sub levels */ | -webkit-transition: opacity .5s ease-in-out; /* Hide sub levels */ | ||
| Line 67: | Line 87: | ||
border:1px solid #444; | border:1px solid #444; | ||
} | } | ||
| - | #navigation ul li:hover>ul{ opacity: 1; position:absolute; top:100%; left:0; | + | #navigation ul li:hover>ul{ opacity: 1; position:absolute; top:100%; left:0; } |
#navigation ul ul li:hover>ul{ position:absolute; top:0; left:100%; opacity: 1; z-index:497;} | #navigation ul ul li:hover>ul{ position:absolute; top:0; left:100%; opacity: 1; z-index:497;} | ||
| - | + | ||
| + | .slideshow img { position:absolute; left:10; top:10; } | ||
| + | |||
| + | .slideshow { | ||
margin: -375px 0px 0px 400px; | margin: -375px 0px 0px 400px; | ||
position: absolute; | position: absolute; | ||
| Line 79: | Line 102: | ||
} | } | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
#footer-box { | #footer-box { | ||
| Line 239: | Line 255: | ||
padding: 0px 16px 50px; | padding: 0px 16px 50px; | ||
} | } | ||
| - | + | ||
| Line 246: | Line 262: | ||
| - | |||
<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> | <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/> | ||
<title>Xayona Website Template</title> | <title>Xayona Website Template</title> | ||
| Line 257: | Line 272: | ||
<div class="page"> | <div class="page"> | ||
<div class="header"> | <div class="header"> | ||
| - | <a href="https://2012.igem.org | + | <a href="https://2012.igem.org"><img src="https://static.igem.org/mediawiki/2012/8/83/Igem_icon.png" style="position:absolute;right:0;top:0;" alt=""></img></a> |
<a href="index.html" id="logo"><img src="https://static.igem.org/mediawiki/2012/c/c2/Michigan_2012_Logo_ani.gif" alt=""/></a> | <a href="index.html" id="logo"><img src="https://static.igem.org/mediawiki/2012/c/c2/Michigan_2012_Logo_ani.gif" alt=""/></a> | ||
<a href="index.html" id="name"><img src="https://static.igem.org/mediawiki/2012/5/5f/Michigan_2012_Site_name.png" alt=""/></a> | <a href="index.html" id="name"><img src="https://static.igem.org/mediawiki/2012/5/5f/Michigan_2012_Site_name.png" alt=""/></a> | ||
| Line 275: | Line 290: | ||
<li><a href="blog.html">Team</a> | <li><a href="blog.html">Team</a> | ||
<ul> | <ul> | ||
| - | <li><a href="#">Option 1</a></li> | + | <li><a href="#">Option 1 </a></li> |
| - | <li><a href="#">Option 2</a></li> | + | <li><a href="#">Option 2 </a></li> |
</ul> | </ul> | ||
</li> | </li> | ||
| Line 286: | Line 301: | ||
<li><a href="services.html">Sponsors</a> | <li><a href="services.html">Sponsors</a> | ||
<ul> | <ul> | ||
| - | <li><a href="#">Option 1</a></li> | + | <li><a href="#"> Option 1 </a></li> |
| - | <li><a href="#">Option 2</a></li> | + | <li><a href="#"> Option 2 </a></li> |
</ul></li> | </ul></li> | ||
</ul> | </ul> | ||
| Line 296: | Line 311: | ||
<div id="featured"> | <div id="featured"> | ||
<h3>Sometimes changes need to be made and with that comes a switch; and a terrible pun.</h3> | <h3>Sometimes changes need to be made and with that comes a switch; and a terrible pun.</h3> | ||
| - | <p>Team Michigan is engineering a novel, tightly controlled and inducible protein expression system in Escherichia coli in order to demonstrate that we can create robust boolean genetic control circuits that do not continuously rely on the presence of signaling compounds. We are using two unidirectional recombinases found in pathogenic Escherichia coli, Hbif, and FimE, to | + | <p>Team Michigan is engineering a novel, tightly controlled and inducible protein expression system in Escherichia coli in order to demonstrate that we can create robust boolean genetic control circuits that do not continuously rely on the presence of signaling compounds. We are using two unidirectional recombinases found in pathogenic Escherichia coli, Hbif, and FimE, to manipulate promoter orientation.</p> |
</div> | </div> | ||
| - | <div | + | <div class="slideshow"> |
| - | + | ||
| - | <img src="https://static.igem.org/mediawiki/2012/0/0d/Michigan_%29Random_Team_1.png"> | + | <img src="https://static.igem.org/mediawiki/2012/0/0d/Michigan_%29Random_Team_1.png" alt=""></img> |
| - | + | ||
| - | + | ||
| - | <img src="https://static.igem.org/mediawiki/2012/a/a0/Michigan_Random_Team_2.png"> | + | <img src="https://static.igem.org/mediawiki/2012/a/a0/Michigan_Random_Team_2.png" alt=""></img> |
| - | + | ||
| - | + | ||
| - | <img src="https://static.igem.org/mediawiki/2012/b/bc/Michigan_Random_Team_3.png"> | + | <img src="https://static.igem.org/mediawiki/2012/b/bc/Michigan_Random_Team_3.png" alt=""></img> |
| - | + | ||
</div> | </div> | ||
</div> | </div> | ||
Latest revision as of 00:35, 7 August 2012
Sometimes changes need to be made and with that comes a switch; and a terrible pun.
Team Michigan is engineering a novel, tightly controlled and inducible protein expression system in Escherichia coli in order to demonstrate that we can create robust boolean genetic control circuits that do not continuously rely on the presence of signaling compounds. We are using two unidirectional recombinases found in pathogenic Escherichia coli, Hbif, and FimE, to manipulate promoter orientation.
